Literature DB >> 11896569

Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

Amy L McDoniels-Silvers1, Gary D Stoner, Ronald A Lubet, Ming You.   

Abstract

The Atlas human cDNA expression array was used to evaluate gene expression profile changes in the genesis of human lung adenocarcinomas and squamous cell carcinomas. Gene expression changes between adenocarcinomas and squamous cell carcinomas were also analyzed. Of the 588 gene targets, 262 genes were expressed in these tissues and, of these, 45 genes were differentially expressed by at least two-fold in tumor tissues compared to corresponding normal tissues. Semiquantitative reverse-transcriptase polymerase chain reaction was used to confirm gene expression changes. Only those genes that reflected changes in >50% of the analyzed tissues were included in the final analysis. Ultimately, 26 genes were evaluated with 14 genes overexpressed and 12 genes underexpressed compared to matching normal lung tissues. Although similar expression changes were detected in adenocarcinomas and squamous cell carcinomas for most of the genes analyzed, some subtype-specific differences were also found. Genes encoding cell cycle regulators, intracellular signal transducers, cell receptor and adhesion molecules, growth factors, oncogenes, and apoptotic effectors were differentially expressed in this study. These gene expression changes may directly contribute to the initiation or progression of human lung cancer or may be secondary effects of the tumorigenesis process. Regardless, many of these differences may be useful in the diagnosis and/or treatment of this deadly disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896569      PMCID: PMC1550320          DOI: 10.1038/sj.neo.7900217

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  59 in total

Review 1.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.

Authors:  S Leppä; D Bohmann
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

2.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

Authors:  A J Ridley; H F Paterson; C L Johnston; D Diekmann; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations.

Authors:  A Schwendel; H Langreck; M Reichel; E Schröck; T Ried; M Dietel; I Petersen
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

Review 4.  Eph-related receptors and their ligands: mediators of contact dependent cell interactions.

Authors:  Q Xu; D G Wilkinson
Journal:  J Mol Med (Berl)       Date:  1997-08       Impact factor: 4.599

Review 5.  Advances in the analysis of chromosome alterations in human lung carcinomas.

Authors:  J R Testa; Z Liu; M Feder; D W Bell; B Balsara; J Q Cheng; T Taguchi
Journal:  Cancer Genet Cytogenet       Date:  1997-05

6.  Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes.

Authors:  T Konishi; Z Lin; S Fujino; H Kato; A Mori
Journal:  Hum Pathol       Date:  1997-05       Impact factor: 3.466

7.  Activity of pp60c-src in 60 different cell lines derived from human tumors.

Authors:  R J Budde; S Ke; V A Levin
Journal:  Cancer Biochem Biophys       Date:  1994-10

8.  Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.

Authors:  M Nishio; T Koshikawa; T Kuroishi; M Suyama; K Uchida; Y Takagi; O Washimi; T Sugiura; Y Ariyoshi; T Takahashi; R Ueda; T Takahashi
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

9.  Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.

Authors:  K Miyazawa; T Shimomura; N Kitamura
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

10.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  9 in total

1.  Cancer progression is mediated by proline catabolism in non-small cell lung cancer.

Authors:  Yating Liu; Chao Mao; Min Wang; Na Liu; Lianlian Ouyang; Shouping Liu; Haosheng Tang; Ya Cao; Shuang Liu; Xiang Wang; Desheng Xiao; Ceshi Chen; Ying Shi; Qin Yan; Yongguang Tao
Journal:  Oncogene       Date:  2020-01-07       Impact factor: 9.867

2.  Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.

Authors:  Ping-Li Sun; Yan Jin; Hyojin Kim; An Na Seo; Sanghoon Jheon; Choon-Taek Lee; Jin-Haeng Chung
Journal:  Virchows Arch       Date:  2013-08-02       Impact factor: 4.064

3.  Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways.

Authors:  Bodo Schniewind; Kirsten Heintz; Roland Kurdow; Ole Ammerpohl; Anna Trauzold; Doris Emme; Peter Dohrmann; Holger Kalthoff
Journal:  J Carcinog       Date:  2006-11-23

4.  The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections.

Authors:  Domenico Mattoscio; Chiara Casadio; Marzia Fumagalli; Mario Sideri; Susanna Chiocca
Journal:  Ecancermedicalscience       Date:  2015-04-29

5.  Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.

Authors:  Yari Ciribilli; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-10-23

6.  [Correlation of aquaporin 3 expression with the clinicopathologic characteristics of non-small cell lung cancer].

Authors:  Bailing Li; Lei Jin; Keng Zhong; Dahai Du
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-07

7.  SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.

Authors:  Fei Han; Ming-Qian Zhang; Wen-Bin Liu; Lei Sun; Xiang-Lin Hao; Li Yin; Xiao Jiang; Jia Cao; Jin-Yi Liu
Journal:  Respir Res       Date:  2018-12-04

8.  High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma.

Authors:  Fei Han; Wenbin Liu; Hualiang Xiao; Yan Dong; Lei Sun; Chengyi Mao; Li Yin; Xiao Jiang; Lin Ao; Zhihong Cui; Jia Cao; Jinyi Liu
Journal:  Sci Rep       Date:  2015-09-02       Impact factor: 4.379

9.  LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of β-catenin.

Authors:  Juntang Yang; Fei Han; Wenbin Liu; Mingqian Zhang; Yongsheng Huang; Xianglin Hao; Xiao Jiang; Li Yin; Hongqiang Chen; Jia Cao; Huidong Zhang; Jinyi Liu
Journal:  J Cancer       Date:  2017-08-02       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.